BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25446513)

  • 21. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery.
    Park JH; Allen MG; Prausnitz MR
    J Control Release; 2005 May; 104(1):51-66. PubMed ID: 15866334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioceramic microneedles with flexible and self-swelling substrate.
    Cai B; Xia W; Bredenberg S; Li H; Engqvist H
    Eur J Pharm Biopharm; 2015 Aug; 94():404-10. PubMed ID: 26126420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intradermal Administration of Influenza Vaccine with Trehalose and Pullulan-Based Dissolving Microneedle Arrays.
    Tian Y; Lee J; van der Maaden K; Bhide Y; de Vries-Idema JJ; Akkerman R; O'Mahony C; Jiskoot W; Frijlink HW; Huckriede ALW; Hinrichs WLJ; Bouwstra JA; Beukema M
    J Pharm Sci; 2022 Apr; 111(4):1070-1080. PubMed ID: 35122832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modelling of dissolving microneedles for transdermal drug delivery: theoretical and experimental aspects.
    Kim KS; Ita K; Simon L
    Eur J Pharm Sci; 2015 Feb; 68():137-43. PubMed ID: 25513710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of transdermal delivery of sumatriptan succinate using a novel self-dissolving microneedle array fabricated from sodium hyaluronate in rats.
    Wu D; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
    Biol Pharm Bull; 2015; 38(3):365-73. PubMed ID: 25757917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chitosan microneedle patches for sustained transdermal delivery of macromolecules.
    Chen MC; Ling MH; Lai KY; Pramudityo E
    Biomacromolecules; 2012 Dec; 13(12):4022-31. PubMed ID: 23116140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, analysis and fabrication of solid polymer microneedle patch using CO
    Anbazhagan G; Suseela SB; Sankararajan R
    Drug Deliv Transl Res; 2023 Jun; 13(6):1813-1827. PubMed ID: 36807879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery.
    Yan G; Warner KS; Zhang J; Sharma S; Gale BK
    Int J Pharm; 2010 May; 391(1-2):7-12. PubMed ID: 20188808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a three-microneedle device for hypodermic drug delivery and clinical application.
    Fukamizu H; Fujiwara M; Kim T; Matsushita Y; Tokura Y
    Plast Reconstr Surg; 2012 Aug; 130(2):451-455. PubMed ID: 22842418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Droplet-born air blowing: novel dissolving microneedle fabrication.
    Kim JD; Kim M; Yang H; Lee K; Jung H
    J Control Release; 2013 Sep; 170(3):430-6. PubMed ID: 23742882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A facile system to evaluate in vitro drug release from dissolving microneedle arrays.
    Larrañeta E; Stewart S; Fallows SJ; Birkhäuer LL; McCrudden MT; Woolfson AD; Donnelly RF
    Int J Pharm; 2016 Jan; 497(1-2):62-9. PubMed ID: 26621687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Katsumi H; Sakane T; Yamamoto A
    J Control Release; 2012 Aug; 161(3):933-41. PubMed ID: 22634072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.
    Al-Qallaf B; Das DB
    Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mass producible and biocompatible microneedle patch and functional verification of its usefulness for transdermal drug delivery.
    Jin CY; Han MH; Lee SS; Choi YH
    Biomed Microdevices; 2009 Dec; 11(6):1195-203. PubMed ID: 19609679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Processing difficulties and instability of carbohydrate microneedle arrays.
    Donnelly RF; Morrow DI; Singh TR; Migalska K; McCarron PA; O'Mahony C; Woolfson AD
    Drug Dev Ind Pharm; 2009 Oct; 35(10):1242-54. PubMed ID: 19555249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simple method of microneedle array fabrication for transdermal drug delivery.
    Kochhar JS; Goh WJ; Chan SY; Kang L
    Drug Dev Ind Pharm; 2013 Feb; 39(2):299-309. PubMed ID: 22519721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ex vivo evaluation of a microneedle array device for transdermal application.
    Indermun S; Choonara YE; Kumar P; du Toit LC; Modi G; van Vuuren S; Luttge R; Pillay V
    Int J Pharm; 2015 Dec; 496(2):351-9. PubMed ID: 26453791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fabrication of a novel partially dissolving polymer microneedle patch for transdermal drug delivery.
    Lee IC; He JS; Tsai MT; Lin KC
    J Mater Chem B; 2015 Jan; 3(2):276-285. PubMed ID: 32261948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tapered conical polymer microneedles fabricated using an integrated lens technique for transdermal drug delivery.
    Park JH; Yoon YK; Choi SO; Prausnitz MR; Allen MG
    IEEE Trans Biomed Eng; 2007 May; 54(5):903-13. PubMed ID: 17518288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microneedle-iontophoresis combinations for enhanced transdermal drug delivery.
    Donnelly RF; Garland MJ; Alkilani AZ
    Methods Mol Biol; 2014; 1141():121-32. PubMed ID: 24567135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.